TI
CYTK icon

Tidal Investments’s Cytokinetics CYTK Stock Holding History

Tidal Investments’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.12M Buy
24,921
+4,938
+25% +$355K ﹤0.01% 1327
2026
Q1 		$1.32M Buy
19,983
+5,995
+43% +$381K ﹤0.01% 1314
2025
Q4 		$889K Buy
13,988
+1,226
+10% +$76.3K ﹤0.01% 1337
2025
Q3 		$701K Sell
12,762
-571
-4% -$23.5K ﹤0.01% 1384
2025
Q2 		$441K Buy
13,333
+4,995
+60% +$174K ﹤0.01% 1487
2025
Q1 		$335K Sell
8,338
-1,627
-16% -$74.8K ﹤0.01% 1508
2024
Q4 		$469K Sell
9,965
-371
-4% -$19.3K ﹤0.01% 1420
2024
Q3 		$546K Buy
10,336
+90
+0.9% +$5.02K 0.01% 1339
2024
Q2 		$555K Buy
+10,246
New +$618K 0.01% 1245

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Tidal Investments's CYTK Position: Q2 2026 in Review

Tidal Investments increased its Cytokinetics (CYTK) stake by 25% in Q2 2026, buying an estimated $355K and bringing the position to 24,921 shares worth $2.12M. The position accounts for ﹤0.01% of the portfolio, ranked #1327.

Tidal Investments first reported a position in CYTK in Q2 2024 and has held it in 9 quarters since. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • Tidal Investments held 24,921 shares of Cytokinetics worth $2.12M as of Q2 2026.
  • Tidal Investments bought 4,938 Cytokinetics shares in Q2 2026, an estimated $355K.
  • Cytokinetics made up ﹤0.01% of Tidal Investments's portfolio in Q2 2026, its #1327 holding.
  • Tidal Investments first reported a position in Cytokinetics in Q2 2024 and has held it in 9 quarters since.
  • 482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.